Commonwealth Equity Services LLC reduced its position in GE HealthCare Technologies by 34.4% during the third quarter, selling 91,088 shares and ending the period with 173,486 shares valued at approximately $13.0 million. Other notable moves included Mirae Asset Global Investments increasing its stake by 4.2% to 159,882 shares, Wedge Capital Management initiating a new position worth about $26.9 million, Valicenti Advisory Services adding 12,550 shares for a 22.6% gain to reach 68,107 shares, and National Bank of Canada FI more than doubling its holding to 899,693 shares. Institutional investors now own just over 82% of outstanding shares.

In the fiscal fourth quarter, GE HealthCare reported earnings per share of $1.07, surpassing analyst consensus by $0.02, on revenues of $5.14 billion, up 5.8% year-over-year and ahead of expectations by $70 million. Return on equity reached 22.5%, while net margin stood at 10.9%. For fiscal 2025, the company has projected EPS in a range implying mid‐single-digit growth over the prior year, reflecting continued strength in imaging and service segment demand.

GE HealthCare declared a quarterly dividend of $0.035 per share, translating to an annualized payout of $0.14 and a yield of approximately 0.2%, with a payout ratio under 3%. Analysts are broadly constructive, with seven Buy ratings and seven Hold ratings assigned over the past quarter, giving GE HealthCare a consensus view of Moderate Buy based on earnings momentum and durable end-market fundamentals.